Research teams at the Virginia Tech Carilion Research Institute from three colleges — Engineering, Science, and Veterinary Medicine — are developing new approaches to treat glioblastoma, the aggressive form of brain cancer recently diagnosed in U.S. Sen. John McCain.
Sometimes it takes a researcher with a flair for entrepreneurship to translate a laboratory breakthrough into a medical treatment. Rob Gourdie, the director of the Virginia Tech Carilion Research Institute’s Center for Heart and Regenerative Medicine Research, uses "intrapreneurship" to translate laboratory breakthroughs into medical treatments.
Warren J. Leonard, a National Institutes of Health Distinguished Investigator and elected member of the National Academy of Medicine, leads the Laboratory of Molecular Immunology at the National Heart, Lung, and Blood Institute in Bethesda, Maryland.
Associate Professor David Brown teamed with scientists from across the U.S. and Europe on a research project that could lead to new approaches for treating the No. 1 killer among men and women worldwide.
Of the more than 3 million people with breast cancer in the United Stated, about 10 percent carry an inherited mutation in their BRCA1 gene. In health, the gene is responsible for suppressing tumors. In disease, the gene goes terribly awry.
The Virginia Tech Carilion School of Medicine is teaming up the with Jefferson College of Health Sciences, Virginia Western Community College, and Virginia Tech’s Translational Biology, Medicine, and Health program for the event.
The conference, set for Oct. 5-7, will bring together neuroscientists, clinicians, and national health science leaders from the National Institutes of Health, and thought leaders from the pharmaceutical industry in the United States and Nordic nations, including Denmark, Finland, Norway, and Sweden.
The doctoral program is the Virginia Tech Graduate School’s largest interdisciplinary program, with more than 200 members of Virginia Tech’s Faculty of Health Sciences teaching and mentoring the students.
A parent’s incarceration has immediate, devastating effects on a family. Now, Virginia Tech and University of Toronto researchers say there’s a longer term risk: Men who as children experienced a family member’s incarceration are approximately twice as likely to have a heart attack in later adulthood in comparison to men who were not exposed to such a childhood trauma.
Scientists at the Virginia Tech Carilion Research Institute have found a potential way to influence long-term memory formation in the immune system. The researchers published their results in Nature Communications.
The same nerves that keep a person from crushing a flower or dropping a water glass are teaching scientists something new about amyotrophic lateral sclerosis. Commonly called ALS or Lou Gehrig’s disease, the neurodegenerative disease has no cure, in part because of the difficult nature of studying the affected cells. A discovery led by Gregorio Valdez, an assistant professor at the Virginia Tech Carilion Research Institute, might make researching the mechanisms of the disease easier.
Virginia Tech’s proposed School of Neuroscience is closer to opening after Board of Visitors' approval.
“This is a step in Virginia Tech’s development into a 21st century land grant university. Every discipline grounded in human decision-making and human interaction will be transformed by our rapidly expanding understanding of how the brain works. Students across the disciplines who participate in our neuroscience curriculum will be in positions to lead in their chosen fields.”